Caspofungin as treatment for Candida glabrata hip infection

被引：25
|
作者：
Lejko-Zupanc, T
Mozina, E
Vrevc, F
机构：
[1] Med Ctr Ljubljana, Dept Infect Dis, Ljubljana 1000, Slovenia
[2] Med Ctr Ljubljana, Inst Radiol, Ljubljana 1000, Slovenia
[3] Med Ctr Ljubljana, Dept Orthopaed Surg, Ljubljana 1000, Slovenia
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2005年 / 25卷 / 03期
关键词：
D O I：
10.1016/j.ijantimicag.2005.01.005
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：273 / 274
页数：2
相关论文
共 50 条
  • [41] CanagliflozinVulvovaginal Candida glabrata infection: case report
    Reactions Weekly, 2019, 1735 (1) : 70 - 70
  • [42] Ventriculoperitoneal shunt infection by Candida glabrata in an adult
    Angel-Moreno, A
    Francés, A
    Granado, JM
    Pérez-Arellano, JL
    JOURNAL OF INFECTION, 2000, 41 (02) : 178 - 179
  • [43] Candida glabrata infection-associated genes
    Mielke, K.
    Kaemmer, P.
    Grosche, L.
    Fichtner, M.
    Shelest, E.
    Guthke, R.
    Brunke, S.
    Hube, B.
    MYCOSES, 2015, 58 : 45 - 45
  • [44] Monitoring of Fluconazole and Caspofungin Activity against In Vivo Candida glabrata Biofilms by Bioluminescence Imaging
    Persyn, Aranka
    Rogiers, Ona
    Brock, Matthias
    Vande Velde, Greetje
    Lamkanfi, Mohamed
    Jacobsen, Ilse D.
    Himmelreich, Uwe
    Lagrou, Katrien
    Van Dijck, Patrick
    Kucharikova, Sona
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (02)
  • [45] Successful treatment of Candida albicans endocarditis with caspofungin
    Kotzalias, N
    Binder, T
    Mueller, C
    Willinger, B
    Graninger, W
    Presterl, E
    TRENDS IN MEDICAL MYCOLOGY, 2003, : 211 - 216
  • [46] Sequential therapy with caspofungin and Fluconazole for Candida albicans infection
    Barchiesi, F
    Spreghini, E
    Baldassarri, I
    Marigliano, A
    Arzeni, D
    Giannini, D
    Scalise, G
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (10) : 4056 - 4058
  • [47] Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection
    Klevay, Michael J.
    Ernst, Erika J.
    Hollanbaugh, Jesse L.
    Miller, Joshua G.
    Pfaller, Michael A.
    Diekema, Daniel J.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2008, 60 (03) : 273 - 277
  • [48] Native valve endocarditis due to Candida glabrata treated without valvular replacement:: A potential role for caspofungin in the induction and maintenance treatment
    Jiménez- Exposito, MJ
    Torres, G
    Baraldés, A
    Benito, N
    Marco, F
    Paré, JC
    Moreno, A
    Claramonte, X
    Mestres, CA
    Almela, M
    de la Maria, CG
    Pérez, N
    Schell, WA
    Corey, GR
    Perfect, J
    de Anta, MTJ
    Gatell, JM
    Miro, JM
    CLINICAL INFECTIOUS DISEASES, 2004, 39 (07) : E70 - E73
  • [49] Identification of Genes in Candida glabrata Conferring Altered Responses to Caspofungin, a Cell Wall Synthesis Inhibitor
    Rosenwald, Anne G.
    Arora, Gaurav
    Ferrandino, Rocco
    Gerace, Erica L.
    Mohammednetej, Maedeh
    Nosair, Waseem
    Rattila, Shemona
    Subic, Amanda Zirzow
    Rolfes, Ronda
    G3-GENES GENOMES GENETICS, 2016, 6 (09): : 2893 - 2907
  • [50] In vivo efficacy of anidulafungin and caspofungin against Candida glabrata and association with in vitro potency in the presence of sera
    Wiederhold, Nathan P.
    Najvar, Laura K.
    Bocanegra, Rosie
    Molina, Destiny
    Livo, Marcos
    Graybill, John R.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (05) : 1616 - 1620
12345